Addex Therapeutics Ltd. (ADXN)
4.06
-1.23
(-23.25%)
USD |
NASDAQ |
Nov 13, 16:00
3.86
-0.20
(-4.93%)
After-Hours: 19:59
Addex Therapeutics Price to Book Value : 1.826 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.826 |
| November 12, 2026 | 2.379 |
| November 11, 2026 | 1.300 |
| November 10, 2026 | 1.300 |
| November 09, 2026 | 1.255 |
| November 06, 2026 | 1.304 |
| November 05, 2026 | 1.304 |
| November 04, 2026 | 1.368 |
| November 03, 2026 | 1.351 |
| November 02, 2026 | 1.345 |
| October 30, 2026 | 1.390 |
| October 29, 2026 | 1.318 |
| October 28, 2026 | 1.331 |
| October 27, 2026 | 1.345 |
| October 26, 2026 | 1.304 |
| October 23, 2026 | 1.336 |
| October 22, 2026 | 1.301 |
| October 21, 2026 | 1.345 |
| October 20, 2026 | 1.372 |
| October 19, 2026 | 1.300 |
| October 16, 2026 | 1.241 |
| October 15, 2026 | 1.358 |
| October 14, 2026 | 1.192 |
| October 13, 2026 | 1.354 |
| October 12, 2026 | 1.367 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.447 |
| October 08, 2026 | 1.430 |
| October 07, 2026 | 1.408 |
| October 06, 2026 | 1.430 |
| October 05, 2026 | 1.394 |
| October 02, 2026 | 1.381 |
| October 01, 2026 | 1.340 |
| September 30, 2026 | 1.241 |
| September 29, 2026 | 1.327 |
| September 28, 2026 | 1.264 |
| September 25, 2026 | 1.641 |
| September 24, 2026 | 1.556 |
| September 23, 2026 | 1.552 |
| September 22, 2026 | 1.574 |
| September 21, 2026 | 1.588 |
| September 18, 2026 | 1.529 |
| September 17, 2026 | 1.511 |
| September 16, 2026 | 1.511 |
| September 15, 2026 | 1.466 |
| September 14, 2026 | 1.565 |
| September 11, 2026 | 1.570 |
| September 10, 2026 | 1.524 |
| September 09, 2026 | 1.623 |
| September 08, 2026 | 1.664 |
| September 04, 2026 | 1.641 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novartis AG | 8.142 |
| Roche Holding AG | -- |
| Oculis Holding AG | 1.892 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Price to Book Value Related Metrics
| PS Ratio | 38.29 |
| PEG Ratio | -0.1222 |
| Price | 4.06 |
| Earnings Yield | -217.0% |
| Market Cap | 4.311M |
| PEGY Ratio | -0.1222 |